V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019002 | 270020066 | 1.82 | 103.9 | Curative (C) | 2017-07-26 | 2017-11-08 | LEAM | 2 | N | 270014996 | LEAM |
| 270019003 | 270009091 | 1.76 | 53.3 | Curative (C) | 2017-06-19 | 2018-03-14 | BEAM | 02 | Y | 270014999 | BEAM |
| 270019004 | 270014257 | 1.84 | 68.9 | Curative (C) | 2017-06-29 | 2017-07-04 | ESHAP | 02 | N | 270015004 | ESHAP |
| 270019005 | 270009099 | null | 54 | Palliative (P) | 2018-05-25 | 2018-05-25 | Rituximab | null | Y | 270015007 | RITUXIMAB |
| 270019006 | 270009102 | 1.75 | null | Curative (C) | 2016-12-12 | 2016-12-26 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015011 | CETUXIMAB + IRINOTECAN + MDG |
| 270019007 | 270018306 | 1.66 | 65 | Curative (C) | 2014-10-20 | 2014-10-23 | BEAM | N | Y | 270015043 | BEAM |
| 270019008 | 270014267 | null | 48.8 | Curative (C) | 2017-11-16 | 2017-12-31 | LEAM | 02 | null | 270015048 | LEAM |
| 270019009 | 270009122 | 1.71 | 78 | Curative (C) | 2016-05-13 | 2016-05-21 | Rituximab | N | null | 270015062 | RITUXIMAB |
| 270019010 | 270009124 | 1.68 | null | Curative (C) | null | 2015-05-21 | Rituximab | 02 | null | 270015063 | RITUXIMAB |
| 270019011 | 270014273 | 1.82 | 97.4 | Palliative (P) | 2014-02-01 | 2014-08-07 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 270015083 | CETUXIMAB + IRINOTECAN + MDG |
| 270019012 | 270014274 | 1.8 | 95 | null | 2013-06-07 | 2013-06-07 | CISPLATIN + RT | N | N | 270015090 | CISPLATIN + RT |
| 270019013 | 270020241 | 1.74 | 56.4 | Curative (C) | null | 2016-02-16 | ESHAP | null | N | 270015099 | ESHAP |
| 270019014 | 270009136 | 1.7 | 68 | Curative (C) | 2017-01-07 | 2017-01-08 | BEAM | 02 | null | 270015104 | BEAM |
| 270019015 | 270009137 | 2.14 | 104 | Curative (C) | 2016-03-31 | 2016-12-01 | ESHAP | N | N | 270015108 | ESHAP |
| 270019016 | 270009143 | 1.91 | 86.9 | null | 2018-11-21 | 2019-03-13 | Cisplatin + Radiotherapy | N | N | 270015115 | CISPLATIN + RT |
| 270019017 | 270009146 | 1.71 | 48.5 | null | 2018-03-29 | 2018-04-05 | Rituximab (Maintenance) | null | null | 270015123 | RITUXIMAB |
| 270019018 | 270009149 | 1.72 | 82 | Curative (C) | 2017-03-18 | 2017-03-19 | LEAM | 02 | N | 270015126 | LEAM |
| 270019019 | 270014281 | null | 97 | Curative (C) | 2018-07-14 | 2018-07-14 | OEPA | N | Y | 270015131 | OEPA |
| 270019020 | 270009156 | 1.63 | 59.7 | Disease modification (D) | 2018-07-09 | 2018-07-15 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270015133 | CISPLATIN + RT |
| 270019021 | 270009160 | null | 90 | Palliative (P) | null | 2018-12-17 | OEPA | 2 | N | 270015146 | OEPA |
| 270019022 | 270019167 | 1.74 | 101.2 | Palliative (P) | 2018-08-27 | 2018-08-29 | BEAM | 02 | Y | 270015192 | BEAM |
| 270019023 | 270009179 | null | 88.5 | Disease modification (D) | null | 2013-09-10 | Rituximab | N | N | 270015218 | RITUXIMAB |
| 270019024 | 270009182 | 1.7 | 81 | Curative (C) | 2017-05-18 | 2017-05-26 | Cisplatin + Radiotherapy | N | N | 270015225 | CISPLATIN + RT |
| 270019025 | 270009183 | 1.53 | 79.2 | null | 2017-08-24 | 2017-08-25 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 270015226 | CETUXIMAB + IRINOTECAN + MDG |
| 270019026 | 270009193 | 1.72 | 53.3 | Curative (C) | 2016-02-10 | 2016-02-11 | OEPA | 02 | N | 270015246 | OEPA |
| 270019027 | 270016849 | 1.77 | 100 | Curative (C) | 2018-04-26 | 2018-05-01 | ESHAP | 02 | N | 270015247 | ESHAP |
| 270019028 | 270009195 | 1.69 | 56.6 | Curative (C) | 2014-10-18 | 2014-12-28 | Cisplatin + Radiotherapy | N | N | 270015247 | CISPLATIN + RT |
| 270019030 | 270009199 | 1.62 | 59 | Palliative (P) | 2016-11-22 | 2017-05-01 | Rituximab | N | N | 270015252 | RITUXIMAB |
| 270019031 | 270009201 | 1.52 | 88 | Palliative (P) | 2017-03-03 | 2017-04-07 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015254 | CETUXIMAB + IRINOTECAN + MDG |
| 270019032 | 270009205 | 1.82 | 70 | Unknown (U) | 2016-11-21 | 2017-02-19 | CHOP R | null | null | 270015269 | CHOP R |
| 270019033 | 270009211 | null | null | Adjuvant (A) | 2017-11-06 | 2017-11-12 | CHLVPP | null | null | 270015275 | CHLVPP |
| 270019034 | 270009214 | null | 52.4 | Curative (C) | 2016-01-08 | 2016-01-26 | Trifluridine + Tipiracil | 02 | N | 270015286 | TRIFLURIDINE + TIPIRACIL |
| 270019035 | 270009218 | 1.76 | 83.36 | Neo-adjuvant (N) | 2015-10-24 | 2015-11-01 | Capecitabine 35days + RT | N | N | 270015293 | CAPECITABINE + RT |
| 270019036 | 270018329 | 1.7 | 76.8 | Palliative (P) | 2016-06-08 | 2017-01-06 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 270015300 | FLUOROURACIL |
| 270019038 | 270016858 | 1.72 | 57 | Curative (C) | 2014-07-03 | 2014-08-03 | DHAP | N | N | 270015309 | DHAP |
| 270019039 | 270009228 | 1.92 | 72 | Adjuvant (A) | 2016-03-27 | 2016-04-24 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 270015310 | CISPLATIN + FLUOROURACIL |
| 270019040 | 270009231 | 1.57 | 88.2 | Neo-adjuvant (N) | 2017-10-12 | 2017-10-18 | CAPECITABINE + RT | N | N | 270015319 | CAPECITABINE + RT |
| 270019041 | 270014316 | 1.7 | null | Curative (C) | null | 2017-11-29 | CHLVPP | 02 | null | 270015329 | CHLVPP |
| 270019042 | 270019178 | null | null | Adjuvant (A) | null | 2015-11-21 | Trifluridine + Tipiracil | null | null | 270015333 | TRIFLURIDINE + TIPIRACIL |
| 270019043 | 270009241 | 1.7 | 92 | Adjuvant (A) | 2017-10-28 | 2017-11-05 | DHAP | 2 | null | 270015339 | DHAP |
| 270019044 | 270009245 | 1.61 | 77 | Curative (C) | 2016-07-08 | 2016-07-08 | CAPECITABINE + RT | N | N | 270015342 | CAPECITABINE + RT |
| 270019045 | 270018336 | 1.76 | 104 | Palliative (P) | 2015-02-05 | 2015-02-05 | Capecitabine (14 day) + Irinotecan | N | Y | 270015350 | CAPECITABINE + IRINOTECAN |
| 270019046 | 270018337 | 1.55 | 66.7 | Adjuvant (A) | 2017-10-14 | 2018-07-10 | Trifluridine + Tipiracil | N | N | 270015353 | TRIFLURIDINE + TIPIRACIL |
| 270019047 | 270009260 | 1.46 | 83.25 | Palliative (P) | 2016-08-05 | 2017-10-18 | Shamash LBCMVD-56 | 02 | N | 270015393 | NOT MATCHED |
| 270019048 | 270019184 | 1.57 | 57.4 | Palliative (P) | 2017-01-27 | 2017-02-04 | CISPLATIN + FLUOROURACIL | 02 | N | 270015404 | CISPLATIN + FLUOROURACIL |
| 270019049 | 270009265 | 1.78 | 100.9 | Adjuvant (A) | 2016-08-11 | 2016-08-18 | Shamash LBCMVD-56 | 02 | Y | 270015410 | NOT MATCHED |
| 270019050 | 270016874 | 1.66 | 94 | Adjuvant (A) | 2019-01-09 | 2019-01-12 | Fluorouricil + Folonic Acid (MdG) | N | N | 270015420 | FLUOROURACIL |
| 270019051 | 270009276 | null | 67.7 | Palliative (P) | 2017-11-29 | 2018-08-08 | Trifluridine + Tipiracil | N | N | 270015458 | TRIFLURIDINE + TIPIRACIL |
| 270019052 | 270009278 | 1.56 | 74.3 | Palliative (P) | 2015-07-24 | 2016-03-24 | Capecitabine (21 day) + Irinotecan | null | null | 270015462 | CAPECITABINE + IRINOTECAN |
| 270019053 | 270016878 | null | 94.7 | Palliative (P) | 2018-12-05 | 2018-12-05 | Capecitabine (21 day) + Irinotecan | N | N | 270015465 | CAPECITABINE + IRINOTECAN |